Stocks and Investing Stocks and Investing
Thu, January 18, 2024

David Nierengarten Reiterated (VOR) at Buy and Held Target at $11 on, Jan 18th, 2024


Published on 2024-10-28 08:24:53 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Reiterated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $11 on, Jan 18th, 2024.

David, nor any peers, have made any analyst calls on VOR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources